Preparation and in vitro characterization of gelatin microspheres containing Levodopa for nasal administration
- 1 January 2000
- journal article
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 17 (6) , 777-784
- https://doi.org/10.1080/02652040050161765
Abstract
Transnasal absorption of pharmaceutical drugs has been recognized as an interesting alternative to the more conventional routes of administration. The aim of this paper was to develop a method of administrating L-dopa following the transnasal route. Gelatin microspheres were prepared by the w/o emulsification solvent extraction technique: the microspheres had a median particle size of 16.2 +/- 4.2 microm and were prepared using a stirring speed of 600 rpm for 5 min at 80 degrees C. The microspheres obtained were spherical and smooth-surfaced, and the microsphere size was inversely proportional to stirring speed (300-700 rpm) and to the percentage of the emulsifier (Tween 85, 1.4-2.7% v/v). L-dopa was incorporated into the microspheres with an efficiency of 65 +/- 6.7%. L-dopa was released from the microspheres, showing an initial fast release rate, followed by a second slower release rate.Keywords
This publication has 7 references indexed in Scilit:
- Oxprenolol release from bioadhesive gelatin/poly(acrylic acid) microspheresJournal of Microencapsulation, 1997
- Preparation, characterisation and in vitro stability of hydrophilic gelatin microspheres using a gelatin-methotrexate conjugateInternational Journal of Pharmaceutics, 1993
- Review: Clinical Opportunities Provided by the Nasal Administration of PeptidesJournal of Drug Targeting, 1993
- Effect of polymers and microspheres on the nasal absorption of insulin in ratsInternational Journal of Pharmaceutics, 1992
- Synthesis of Gelatin Microspheres Containing InterferonPharmaceutical Research, 1989
- Dosage form Design for Improvement of Bioavailability of Levodopa V: Absorption and Metabolism of Levodopa in Intestinal Segments of DogsJournal of Pharmaceutical Sciences, 1981
- Dosage form design for improvement of bioavailability of levodopa III: Influence of dose on pharmacokinetic behavior of levodopa in dogs and parkinsonian patientsJournal of Pharmaceutical Sciences, 1980